Diabetes drug alleviates anxiety in mice

Diabetes drug alleviates anxiety in mice
Model underpinning the effects of metformin on depressive symptoms in mice fed a HFD. Credit: Zemdegs et al., JNeurosci (2019)

The antidiabetic medication metformin reduces anxiety-like behaviors in male mice by increasing serotonin availability in the brain, according to a study published in JNeurosci. These findings could have implications for the treatment of patients with both metabolic and mental disorders.

People with diabetes have an increased risk for mood disorders such as depression. Although the mechanisms underlying the relationship between —the precursor to diabetes—and depression are not known, studies suggest the may be the culprit.

In mice raised on a , Bruno Guiard and colleagues demonstrate that the insulin-sensitizing drug metformin reduces levels of amino acids that impair the entry of tryptophan in the brain and thereby limit its conversion into serotonin. The drug's antidepressant-like effects were accompanied by improved neurotransmission in the hippocampus.

The researchers achieved similar effects by reducing the amount of so-called branched chained amino acids in the diet.

More information: Metformin promotes anxiolytic and antidepressant-like responses in insulin-resistant mice by decreasing circulating branched-chain amino acids , JNeurosci (2019). DOI: 10.1523/JNEUROSCI.2904-18.2019

Journal information: Journal of Neuroscience
Citation: Diabetes drug alleviates anxiety in mice (2019, June 3) retrieved 13 April 2024 from https://medicalxpress.com/news/2019-06-diabetes-drug-alleviates-anxiety-mice.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

High-fat diet may cause changes in the brain that lead to anxiety and depression


Feedback to editors